ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $42,170,000 | +30.5% | 910,206 | -31.3% | 0.09% | +24.7% |
| Q1 2019 | $32,308,000 | +23.1% | 1,325,190 | -28.1% | 0.07% | +12.3% |
| Q4 2018 | $26,251,000 | -25.0% | 1,842,171 | -20.0% | 0.06% | -9.7% |
| Q3 2018 | $34,982,000 | +4.3% | 2,301,455 | +15.1% | 0.07% | +1.4% |
| Q2 2018 | $33,551,000 | +89.3% | 1,999,490 | +84.1% | 0.07% | +86.8% |
| Q1 2018 | $17,723,000 | +1492.4% | 1,086,011 | +1148.9% | 0.04% | +1800.0% |
| Q4 2017 | $1,113,000 | +12.9% | 86,956 | +8.5% | 0.00% | 0.0% |
| Q3 2017 | $986,000 | +46.9% | 80,175 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $671,000 | +12.8% | 80,175 | +20.4% | 0.00% | +100.0% |
| Q1 2017 | $595,000 | +7.4% | 66,573 | +5.5% | 0.00% | 0.0% |
| Q4 2016 | $554,000 | +30.0% | 63,079 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $426,000 | +89.3% | 63,079 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $225,000 | +21.0% | 63,079 | 0.0% | 0.00% | – |
| Q1 2016 | $186,000 | -30.1% | 63,079 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $266,000 | -7.6% | 63,079 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $288,000 | -45.6% | 63,079 | -14.1% | 0.00% | 0.0% |
| Q2 2015 | $529,000 | -7.2% | 73,398 | -5.1% | 0.00% | 0.0% |
| Q1 2015 | $570,000 | +55.7% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $366,000 | +32.6% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $276,000 | -21.8% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $353,000 | -2.8% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $363,000 | -6.2% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $387,000 | -19.5% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $481,000 | +37.0% | 77,330 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $351,000 | – | 77,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |